v3.26.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
OPERATING ACTIVITIES:      
Net income $ 33,128 $ 20,154 $ 10,528
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation 3,827 3,654 3,997
Deferred income taxes 4,516 (3,837) (1,454)
Stock-based compensation expense 4,552 3,869 4,647
Provision for credit losses 168 (244) (160)
Right-of-use asset impairment   14,079  
Loss (gain) on disposition of property, plant and equipment 92 (9,446) (2,839)
Changes in operating assets and liabilities:      
Trade receivables (7,596) 9,253 (5,910)
Inventories (1,458) 7,441 25,499
Other current and non-current assets 3,396 (8,548) (8,199)
Accounts payable - trade 10,862 (579) 1,373
Accrued liabilities (281) 830 4,177
Other long-term liabilities 311 353 224
Net cash provided by operating activities 51,517 36,979 31,883
INVESTING ACTIVITIES:      
Proceeds from sale of investments   1,155  
Proceeds from sales of property, plant and equipment 21 11,535 4,179
Capital expenditures (3,941) (3,258) (4,772)
Net cash (used in) provided by investing activities (3,920) 9,432 (593)
FINANCING ACTIVITIES:      
Dividends paid (4,375) (3,556) (3,219)
Treasury stock purchases (63,746)   (1,659)
Proceeds from lines of credit 9,000 202,344 367,818
Payments on lines of credit (9,000) (207,262) (391,270)
Proceeds from issuance of common stock 70 141 88
Shares withheld for tax payments on vested shares and options exercised (2,874) (2,833) (1,652)
Net cash (used in) financing activities (70,925) (11,166) (29,894)
(Decrease) increase in cash and cash equivalents (23,328) 35,245 1,396
Cash and cash equivalents at beginning of year 40,006 4,761 3,365
Cash and cash equivalents at end of year 16,678 40,006 4,761
SUPPLEMENTAL INFORMATION      
Interest paid 22 107 1,694
Interest received 1,288 421  
Cash paid for income taxes, net 8,109 9,397 4,296
Capital expenditures in accounts payable $ 149 $ 390 $ 23